Narodna in univerzitetna knjižnica, Ljubljana (NUK)
Naročanje gradiva za izposojo na dom
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi
  • Glavkom in možnosti nevroprotektivnega zdravljenja = Glaucoma and options for neuroprotective treatment
    Zupan, Marija, okulistika, 1941- ; Gril, Alenka, 1977-
    Background: Glaucoma is a chronic progresssive optic neuropathy that often progresses despite lowering of intraocular pressure (IOP) to target levels. A need exists for therapies that prevent or ... limit the damage due to glaucoma, independent of therapies that simply lower IOP. The aim of neuroprotection in glaucoma is to slow down the progression by blocking the mechanisms that lead to apoptosis. Conclusions: The neuroprotective effect was demonstrated with brimonidine and betaxolol in clinical trial till now. Ginkgo biloba showed improvement of visual field damage in clinical studies on a small number of patients with NTG. Intravitreal application of Pralnacasan showed reduced ganglion cell apoptosis in an animal model with induced glaucoma. Vaccination with Glatiramer acetate has entered phase 2 trials for use in glaucoma patients.
    Vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 79, supl., dec. 2010, str. I-135-I-158)
    Vrsta gradiva - članek, sestavni del
    Leto - 2010
    Jezik - slovenski
    COBISS.SI-ID - 27820505

    Povezava(-e):

    http://szd.si/user_files/vsebina/Zdravniski_Vestnik/2010/suplement/i-153-8.pdf
    Digitalna knjižnica Slovenije - dLib.si

Vnos na polico